Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Alopecia | postmarketing | x | x | x | |
| Dermatitis | postmarketing | x | x | x | |
| Headache | postmarketing | x | x | x | |
| Pain | postmarketing | x | x | x | |
| Paraesthesia | postmarketing | x | x | x | |
| Pruritus | postmarketing | x | x | x | |
| Urticaria | postmarketing | x | x | x | |
| Dizziness | x | x | x | ||
| Convulsion | x | x | x | ||
| Dermatitis irritant contact | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Infestation NOS | x | x | x | ||
| Lice infestation | x | ||||
| Scabies | x | ||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |